315 results
Page 8 of 16
8-K
rd1ub9hvt4ar
16 Mar 12
Discovery Labs Prices $45.0 Million Public Offering of
12:00am
8-K
EX-1.1
x2tyfdb
16 Mar 12
Discovery Labs Prices $45.0 Million Public Offering of
12:00am
424B5
xcqrj8oz 1wls
15 Mar 12
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
t8xxwmop9jrw 58s17
7 Mar 12
Discovery Labs Announces FDA Approval of SURFAXIN® (lucinactant) for Prevention of Respiratory Distress Syndrome
12:00am
424B5
4ronzzd
15 Dec 11
Prospectus supplement for primary offering
12:00am
8-K
EX-10.1
d6s9e7xh24v9qppj
14 Dec 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
n0v31o yduqxnvoj
28 Sep 11
Other Events
12:00am
8-K
EX-99.1
dc1ysa2
6 Sep 11
Discovery Labs Submits SURFAXIN® Complete Response to FDA
12:00am
8-K
xd8sdfvec
29 Jul 11
Other Events
12:00am
8-K
EX-99.1
86f41ku
29 Jul 11
Other Events
12:00am
8-K
EX-99.1
9zpm09jmxt8luasrj
1 Jun 11
Other Events
12:00am
424B5
sjk2rf54sgp5
17 Feb 11
Prospectus supplement for primary offering
12:00am
8-K
EX-1.1
go6v7y
16 Feb 11
Discovery Labs Prices $23.5 Million Public Offering of
12:00am
424B5
nvi31km dll8fr
15 Feb 11
Prospectus supplement for primary offering
12:00am
8-K
0hll0yhvzc09r0h
9 Feb 11
Other Events
12:00am